QUANTINUUM TARGETS $1.46B IN EXPANDED IPO

AI DESK■ 1 MIN READ

MON, JUN 1, 2026

■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE

Quantum computing startup Quantinuum has increased its initial public offering, planning to sell 26.5 million shares at $53-$55 each. The offering could raise up to $1.46 billion and value the Honeywell-backed company at $14.3 billion.

Quantinuum filed updated terms with the SEC for its upcoming IPO, boosting the share count and price range from earlier plans. At the midpoint of the proposed range, the offering would raise approximately $1.4 billion. The quantum computing company, backed by industrial conglomerate Honeywell International, operates in a sector attracting significant investor attention and venture capital funding. Quantum computing firms are developing hardware and software to solve complex computational problems beyond the reach of classical computers. Quantinuum's IPO comes amid broader market activity in the quantum computing space, where companies are racing to demonstrate practical applications and scalability. The company has previously partnered with major tech firms and research institutions on quantum projects. The pricing range and share count reflect market conditions and investor demand. Final pricing is expected following a roadshow with institutional investors.

■ SOURCES

► Techmeme

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

P402AI INFRASTRUCTURE STARTUPS MODAL, BASETEN RAISE FUNDING

Modal Labs and Baseten, two platforms enabling businesses to run AI models, are in advanced funding talks that would significantly boost their valuations. The rounds reflect growing investor appetite for AI infrastructure services.

10H AGO— AI Desk

P395EMA RAISES $77M SERIES B FOR AI PROCESS AUTOMATION

Ema, an AI agent platform automating corporate processes in HR, IT, and finance, secured $77 million in Series B funding led by Creaegis. The round brings the startup's total funding to $140 million.

12H AGO— AI Desk

P385ENVEDA LANDS $311M FOR NATURE-BASED AI DRUG TRIALS

Enveda Therapeutics raised $311 million in funding, bringing the AI biotech company's valuation to $2 billion. The capital will accelerate clinical trials for drugs derived from natural compounds.

13H AGO— AI Desk

P375TEKEVER RAISES $580M ON $6.4B VALUATION

Portuguese surveillance drone maker Tekever secured $580 million in funding led by UC Investments, reaching a $6.4 billion valuation. The raise follows a major £400 million, 10-year contract with UK Ministry of Defence.

15H AGO— AI Desk

◄ BACK TO NEWS

QUANTINUUM TARGETS $1.46B IN EXPANDED IPO

■ MORE FROM THE STARTUPS DESK

■ SUBSCRIBE TO THE DAILY BRIEF